Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial nucleases are a diverse class of enzymes, including deoxyribonucleases (DNases) and ribonucleases (RNases), that play critical roles in the survival and pathogenicity of bacterial species [1, 5]. These enzymes are involved in essential intracellular processes such as DNA replication, repair, and recombination, as well as the acquisition of nutrients through the scavenging of environmental nucleotides [1, 8]. Many pathogenic bacteria, notably Staphylococcus aureus and Streptococcus pneumoniae, secrete extracellular nucleases as virulence factors to degrade the DNA matrix of neutrophil extracellular traps (NETs), allowing the pathogen to evade the host’s innate immune system [3, 8, 10]. Additionally, these enzymes modulate the structural integrity of biofilms by cleaving extracellular DNA (eDNA), which facilitates biofilm formation, dispersal, or remodeling [1, 13]. Targeting these nucleases with small-molecule inhibitors, such as benzimidazole-based ligands, is a promising anti-virulence strategy intended to restore host immune clearance and increase bacterial susceptibility to traditional antibiotics without exerting the high selective pressure of bactericidal agents [3, 12]. Furthermore, bacterial nuclease activity is increasingly utilized as a diagnostic biomarker for identifying specific bacterial infections and monitoring therapeutic efficacy [5, 11].
Inhibition of nuclease-mediated hydrolysis of nucleic acids to restore host neutrophil extracellular trap (NET) function and impair biofilm stability [3, 8].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial nuclease.